世界の止血診断市場2017年ー2025年:製品タイプ別(ラボシステム、消耗品、ポイントオブケア検査システム)、検査タイプ別、エンドユーザー別

◆英語タイトル:Hemostasis Diagnostics Market (Product Type - Laboratory Systems, Consumables, and Point-of-Care Testing Systems; Test Type - Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer; End Users - Hospital/Clinics, Independent Diagnostic Laboratories, and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
◆商品コード:TMR21MC012
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2020年11月16日
◆ページ数:189
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥660,630見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD8,795 ⇒換算¥1,002,630見積依頼/購入/質問フォーム
Enterprisewide Licence(複数拠点内共有可)USD11,795 ⇒換算¥1,344,630見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Research社の本調査資料では、世界の止血診断市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品タイプ別(ラボシステム、消耗品、ポイントオブケア検査システム)分析、検査タイプ別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でまとめております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・止血診断の世界市場規模:製品タイプ別(ラボシステム、消耗品、ポイントオブケア検査システム)
・止血診断の世界市場規模:検査タイプ別
・止血診断の世界市場規模:エンドユーザー別
・止血診断の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況
【レポートの概要】

Global Hemostasis Diagnostics Market – Scope of Report

TMR’s report on the global hemostasis diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global hemostasis diagnostics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hemostasis diagnostics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hemostasis diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Hemostasis Diagnostics Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global hemostasis diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hemostasis diagnostics market.

The report delves into the competitive landscape of the global hemostasis diagnostics market. Key players operating in the global hemostasis diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hemostasis diagnostics market that have been profiled in this report.

Key Questions Answered in Global Hemostasis Diagnostics Market Report

What is the scope of growth of product companies in the global hemostasis diagnostics market?
What will be the Y-o-Y growth of the global hemostasis diagnostics market between 2019 and 2027?
What is the influence of changing trends in technologies on the global hemostasis diagnostics market?
Will North America continue to be the most profitable market for hemostasis diagnostics devices providers?
Which factors are anticipated to hamper the growth of the global hemostasis diagnostics market during the forecast period?
Which are the leading companies in the global hemostasis diagnostics market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global hemostasis diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global hemostasis diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the hemostasis diagnostics market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the hemostasis diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global hemostasis diagnostics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global hemostasis diagnostics market more reliably and accurately.

Regional Segmentation of Hemostasis Diagnostics Market

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemostasis Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemostasis Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Coagulation Disorders & Coagulation Pathways: Overview
5.2. Epidemiology: Coagulation Disorders
5.3. Regulatory Framework
5.4. Reimbursement Scenario
5.5. Hemostasis Diagnostics Market: Pricing Analysis
5.6. Hemostasis Diagnostics Market: Value Chain Analysis
5.7. Hemostasis Diagnostics Market: Porter’s Five Forces Analysis
6. Global Hemostasis Diagnostics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Hemostasis Diagnostics Market Value Forecast, by Product Type, 2017–2027
6.2.1. Laboratory Systems
6.2.1.1. Automated Systems
6.2.1.2. Semi-automated Systems
6.2.1.3. Manual Systems
6.2.2. Consumables
6.2.3. Point-of-Care Testing Systems
6.3. Global Hemostasis Diagnostics Market Attractiveness, by Product Type
7. Global Hemostasis Diagnostics Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Hemostasis Diagnostics Market Value Forecast, by Test Type, 2017–2027
7.2.1. Prothrombin Test Time (PT)
7.2.2. Activated partial thromboplastin time (APTT)
7.2.3. Fibrinogen degradation products (FDP)
7.2.4. Activated Clotting Time
7.2.5. Platelet Aggregation Test
7.2.6. D Dimer
7.2.7. Others
7.3. Global Hemostasis Diagnostics Market Attractiveness, by Test Type
8. Global Hemostasis Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Hemostasis Diagnostics Market Value Forecast, by End-user, 2017–2027
8.2.1. Hospital/Clinics
8.2.2. Independent Diagnostic Laboratories
8.2.3. Home Care Settings
8.2.4. Others
8.3. Global Hemostasis Diagnostics Market Attractiveness, by End-user
9. Global Hemostasis Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Hemostasis Diagnostics Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Hemostasis Diagnostics Market Attractiveness, by Region
10. North America Hemostasis Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
10.2.1. Laboratory Systems
10.2.1.1. Automated Systems
10.2.1.2. Semi-automated Systems
10.2.1.3. Manual Systems
10.2.2. Consumables
10.2.3. Point-of-Care Testing Systems
10.3. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
10.3.1. Prothrombin Test Time (PT)
10.3.2. Activated partial thromboplastin time (APTT)
10.3.3. Fibrinogen degradation products (FDP)
10.3.4. Activated Clotting Time
10.3.5. Platelet Aggregation Test
10.3.6. D Dimer
10.3.7. Others
10.4. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
10.4.1. Hospital/Clinics
10.4.2. Independent Diagnostic Laboratories
10.4.3. Home Care Settings
10.4.4. Others
10.5. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Hemostasis Diagnostics Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Test Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Hemostasis Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
11.2.1. Laboratory Systems
11.2.1.1. Automated Systems
11.2.1.2. Semi-automated Systems
11.2.1.3. Manual Systems
11.2.2. Consumables
11.2.3. Point-of-Care Testing Systems
11.3. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
11.3.1. Prothrombin Test Time (PT)
11.3.2. Activated partial thromboplastin time (APTT)
11.3.3. Fibrinogen degradation products (FDP)
11.3.4. Activated Clotting Time
11.3.5. Platelet Aggregation Test
11.3.6. D Dimer
11.3.7. Others
11.4. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
11.4.1. Hospital/Clinics
11.4.2. Independent Diagnostic Laboratories
11.4.3. Home Care Settings
11.4.4. Others
11.5. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Hemostasis Diagnostics Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Test Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Hemostasis Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
12.2.1. Laboratory Systems
12.2.1.1. Automated Systems
12.2.1.2. Semi-automated Systems
12.2.1.3. Manual Systems
12.2.2. Consumables
12.2.3. Point-of-Care Testing Systems
12.3. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
12.3.1. Prothrombin Test Time (PT)
12.3.2. Activated partial thromboplastin time (APTT)
12.3.3. Fibrinogen degradation products (FDP)
12.3.4. Activated Clotting Time
12.3.5. Platelet Aggregation Test
12.3.6. D Dimer
12.3.7. Others
12.4. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
12.4.1. Hospital/Clinics
12.4.2. Independent Diagnostic Laboratories
12.4.3. Home Care Settings
12.4.4. Others
12.5. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Test Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Hemostasis Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
13.2.1. Laboratory Systems
13.2.1.1. Automated Systems
13.2.1.2. Semi-automated Systems
13.2.1.3. Manual Systems
13.2.2. Consumables
13.2.3. Point-of-Care Testing Systems
13.3. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
13.3.1. Prothrombin Test Time (PT)
13.3.2. Activated partial thromboplastin time (APTT)
13.3.3. Fibrinogen degradation products (FDP)
13.3.4. Activated Clotting Time
13.3.5. Platelet Aggregation Test
13.3.6. D Dimer
13.3.7. Others
13.4. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
13.4.1. Hospital/Clinics
13.4.2. Independent Diagnostic Laboratories
13.4.3. Home Care Settings
13.4.4. Others
13.5. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America Latin America
13.6. Latin America Hemostasis Diagnostics Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Test Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Hemostasis Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
14.2.1. Laboratory Systems
14.2.1.1. Automated Systems
14.2.1.2. Semi-automated Systems
14.2.1.3. Manual Systems
14.2.2. Consumables
14.2.3. Point-of-Care Testing Systems
14.3. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
14.3.1. Prothrombin Test Time (PT)
14.3.2. Activated partial thromboplastin time (APTT)
14.3.3. Fibrinogen degradation products (FDP)
14.3.4. Activated Clotting Time
14.3.5. Platelet Aggregation Test
14.3.6. D Dimer
14.3.7. Others
14.4. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
14.4.1. Hospital/Clinics
14.4.2. Independent Diagnostic Laboratories
14.4.3. Home Care Settings
14.4.4. Others
14.5. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Test Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share / Position Analysis, by Company, 2018
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Abbott Laboratories, Inc.
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Financial Analysis
15.4.1.3. Growth Strategies
15.4.1.4. SWOT Analysis
15.4.2. Thermo Fisher Scientific, Inc
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Financial Analysis
15.4.2.3. Growth Strategies
15.4.2.4. SWOT Analysis
15.4.3. F. Hoffmann-La Roche Ltd
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Financial Analysis
15.4.3.3. Growth Strategies
15.4.3.4. SWOT Analysis
15.4.4. Nihon Kohden Corporation
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Financial Analysis
15.4.4.3. Growth Strategies
15.4.4.4. SWOT Analysis
15.4.5. Sysmex Corporation
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Financial Analysis
15.4.5.3. Growth Strategies
15.4.5.4. SWOT Analysis
15.4.6. Siemens Healthineers
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Financial Analysis
15.4.6.3. Growth Strategies
15.4.6.4. SWOT Analysis
15.4.7. Instrumentation Laboratory
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Financial Analysis
15.4.7.3. Growth Strategies
15.4.7.4. SWOT Analysis
15.4.8. Danaher Corporation (Beckman Coulter)
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Financial Analysis
15.4.8.3. Growth Strategies
15.4.8.4. SWOT Analysis
15.4.9. Grifols, S.A.
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Growth Strategies
15.4.9.3. SWOT Analysis

List of Table

Table 01: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019–2027

Table 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 03: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2027

Table 04: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Region, 2019–2027

Table 05: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019–2027

Table 06: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2019–2027

Table 07: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019–2027

Table 08: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2019–2027

Table 09: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019–2027

Table 10: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2019–2027

Table 11: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019–2027

Table 12: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2019–2027

Table 13: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019–2027

Table 14: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2019–2027

Table 15: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019–2027

Table 16: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2019–2027

Table 17: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2027

Table 18: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 19: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019–2027

Table 20: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2027

Table 22: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 23: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019–2027

Table 24: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figure

Figure 01: Hemostasis Diagnostics Market Snapshot

Figure 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 03: Market Value Share By Product (2018)

Figure 04: Market Value Share By End-user (2018)

Figure 05: Market Value Share By Region(2018)

Figure 06: Global Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 07: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laboratory Systems, 2017–2027

Figure 08: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2017–2027

Figure 09: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Point-of-care Testing Systems, 2017–2027

Figure 10: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Systems, 2017–2027

Figure 11: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Semi-automated Systems, 2017–2027

Figure 12: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Manual Systems, 2017–2027

Figure 13: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Product

Figure 14: Global Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 15: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prothrombin Time (PT), 2017–2027

Figure 16: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by APTT, 2017–2027

Figure 17: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fibrinogen Degradation Products (FDP), 2017–2027

Figure 18: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Activated Clotting Time, 2017–2027

Figure 19: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Platelet Aggregation Test, 2017–2027

Figure 20: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by D Dimer, 2017–2027

Figure 21: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 22: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type

Figure 23: Global Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 24: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital & Clinics, 2017–2027

Figure 25: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Diagnostic Laboratories, 2017–2027

Figure 26: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home Care Settings, 2017–2027

Figure 27: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 28: Global Hemostasis Diagnostics Market Attractiveness Analysis, by End-user

Figure 29: Global Hemostasis Diagnostics Market Value Share Analysis, by Region, 2018 and 2027

Figure 30: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Region

Figure 31: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2019–2027

Figure 32: North America Hemostasis Diagnostics Market Attractiveness Analysis, by Country

Figure 33: North America Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 34: North America Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 35: North America Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 36: North America Hemostasis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 37: North America Hemostasis Diagnostics Market Attractiveness, by Product

Figure 38: North America Hemostasis Diagnostics Market Attractiveness, by Test Type

Figure 39: North America Hemostasis Diagnostics Market Attractiveness, by End-user

Figure 40: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2019–2027

Figure 41: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Country

Figure 42: Europe Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 43: Europe Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 44: Europe Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 45: Europe Hemostasis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 46: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Product

Figure 47: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type

Figure 48: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by End-user

Figure 49: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017– 2027

Figure 50: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Country 2019–2027

Figure 51: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 52: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 53: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 54: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 55: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Product

Figure 56: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type

Figure 57: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by End-user

Figure 58: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 59: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 60: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 61: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 62: Latin America Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 63: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Product

Figure 65: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type

Figure 66: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by End-user

Figure 67: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2017–2027

Figure 68: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Country/Sub-region

Figure 69: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 70: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 71: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 72: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 73: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Product

Figure 74: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type

Figure 75: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by End-user

Figure 76: Global Hemostasis Diagnostics Market Share Analysis, by Company (2018)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の止血診断市場2017年ー2025年:製品タイプ別(ラボシステム、消耗品、ポイントオブケア検査システム)、検査タイプ別、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆